EASD e-Learning’s Post

When a country faces war or natural disaster, it will face unique challenges in caring for its population with diabetes. In a session at the 59th Annual Meeting of the European Association for the Study of Diabetes e.V. (EASD) called ‘Facing the unexpected: how to fight diabetes when you’re fighting a war or disaster’, Butheinah Al-Sharafi, Professor of Medicine and Consultant Endocrinologist at Sana’a University, Yemen, spoke about the challenges faced by people with diabetes in Yemen, Iraq and Syria. Read our report - link in comments #diabetes

Tirzepatide, the long-acting GIP and GLP-1 dual agonist, has already shown value in lowering HbA1c in the SURPASS trials. At the 59th Annual Meeting of the European Association for the Study of Diabetes e.V. (EASD), new findings from SURPASS were presented, revealing that tirzepatide comes with some extra benefits. Read our report: https://lnkd.in/e3c3NFqW #diabetes

In the latest episode of our Gamechangers video series, Professor John Buse discusses the paper that could change the future of screening for type 1 diabetes. Full clip on our site: https://lnkd.in/eP8g5zd7 #diabetes #t1d #type1diabetes

The combination of AG019, a bacterium expressing human proinsulin and human IL-10, with the anti-CD3 antibody teplizumab, has shown promise for type 1 diabetes in preclinical research. The first-in-human study is reported in Diabetologia, showing this combination is both safe and shows promising signs of clinical efficacy. Read our report: https://lnkd.in/ePDwW9MB #diabetes #t1d #type1diabetes

‘Epidemiologic trends and disparities in diabetes risk factors among LGBTQ+ populations’ was the title of a presentation at the 59th Annual Meeting of the European Association for the Study of Diabetes e.V. (EASD), and it highlighted the need for more detailed research into the mechanisms behind them. Read our report: https://lnkd.in/d2avaNJ3 #diabetes #LGBTQ

The importance of precision: one patient’s response to a diet opened Professor Mikael Ryden’s eyes to the difficulties of generalised recommendations. #Diabetes #DiabetesCare More patient case studies on our site - link in comments